Silverarc Capital Management, LLC Portfolio Holdings
Silverarc Capital Management, LLC
- $414 Million
- Q2 2025
Silverarc Capital Management, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $414 Million distributed in 65 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $39M, Akero Therapeutics, Inc. with a value of $38.1M, Verona Pharma PLC with a value of $33.9M, Uro Gen Pharma Ltd. with a value of $27.7M, and Rhythm Pharmaceuticals, Inc. with a value of $25.3M.
Examining the 13F form we can see an increase of $3.04M in the current position value, from $411M to 414M.
Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.